DXDISCOVERY
Live / Registered — Registered (as of 06 Aug 2024)
What this means for you
Registered since 06 Aug 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90823017
- Registration number
- 7469256
- Mark type
- Stylized text
- Filed
- 12 Jul 2021
- Published for opposition
- 14 Feb 2023
- Registered
- 06 Aug 2024
- Attorney of record
- Matthew D. Francis
Goods and services
- Class 001 — Chemicals: Assays for research purposes; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use
- Class 005 — Pharmaceuticals: Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, invasive candidiasis, Lyme disease, Pertussis, Cryptococcosis, Dermatophyte infection, Mucormycosis, Huanglongbing, and Bacillus anthracis (anthrax); Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Immunoassay reagents for medical use; Medical diagnostic reagents and assays for testing body fluids for microorganisms
- Class 042 — Scientific and technological services: Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Custom design and development of chemical reagents and biochemical assays; Pharmaceutical research and development; Research and development services in the field of antibodies; Research and development in the pharmaceutical and biotechnology fields; Research and development in the field of immunoassay; Research and development of vaccines and medicines; Scientific research and development; Vaccine research and development
Owner
- DxDiscovery, Inc., Reno, NV, US
- DxDiscovery, Inc., Reno, NV, US
- DxDiscovery, Inc., Reno, NV, US
Prosecution history
- 06 Aug 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Aug 2024 — REGISTERED-PRINCIPAL REGISTER
- 03 Jul 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Jul 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 19 Mar 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Mar 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Mar 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 18 Mar 2024 — ASSIGNED TO LIE
- 31 Oct 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Oct 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Oct 2023 — NON-FINAL ACTION E-MAILED
- 05 Oct 2023 — SU - NON-FINAL ACTION - WRITTEN
- 17 Aug 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Aug 2023 — USE AMENDMENT FILED
- 17 Aug 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL